MIA Antikörper (AA 87-124) (HRP)
-
- Target Alle MIA Antikörper anzeigen
- MIA (Melanoma Inhibitory Activity (MIA))
-
Bindungsspezifität
- AA 87-124
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MIA Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Melanoma-derived growth regulatory protein (87-124AA)
- Isotyp
- IgG
- Top Product
- Discover our top product MIA Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- MIA (Melanoma Inhibitory Activity (MIA))
- Andere Bezeichnung
- MIA (MIA Produkte)
- Hintergrund
-
Background: Elicits growth inhibition on melanoma cells in vitro as well as some other neuroectodermal tumors, including gliomas.
Aliases: Cartilage derived retinoic acid sensitive protein antibody, CD RAP antibody, CDRAP antibody, Melanoma derived growth regulatory protein precursor antibody, Melanoma inhibitory activity protein antibody, Melanoma-derived growth regulatory protein antibody, Mia antibody, MIA_HUMAN antibody
- UniProt
- Q16674
-